Panel releases first Australasian guidance on vulval lichen sclerosus
The multidisciplinary consensus statement deviates from overseas advice in advocating long-term maintenance therapy
Topical corticosteroids (TCS) for vulval lichen sclerosus should be continued even when patients are asymptomatic, and follow-up should be maintained “indefinitely”, new clinical management advice states.
The panel of 22 doctors from Australia and New Zealand who developed the advice said studies had shown that such long-term therapy improved function and relieved symptoms as well as minimising scarring and carcinoma of the vulva.
